Hypospadias: Pathophysiology and etiologic theories

Pediatric Endocrinology Reviews

Volumn 1, Issue 3, 2004, Pages 288-295

  Kurzrock, Eric A ^a,b   Karpman, Edward ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Androgen; Etiology; Hypospadias; Male; Penis; Testosterone; Urethra

Indexed keywords

ANDROGEN RECEPTOR; MUELLERIAN INHIBITING FACTOR; STEROID 5ALPHA REDUCTASE; TESTOSTERONE;

ANATOMY; ANDROGEN SYNTHESIS; CHROMOSOME ABERRATION; DNA BINDING; EMBRYO DEVELOPMENT; EMBRYOLOGY; ENVIRONMENTAL FACTOR; ENZYME DEFICIENCY; EPIDEMIOLOGICAL DATA; FERTILIZATION IN VITRO; GENE FUNCTION; GENE MUTATION; GONAD DEVELOPMENT; HIGH RISK POPULATION; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HUMAN; HYPOSPADIAS; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; MALE PSEUDOHERMAPHRODITISM; MASCULINITY; MATERNAL AGE; MATERNAL NUTRITION; MORPHOGENESIS; PATHOPHYSIOLOGY; RECEPTOR INTRINSIC ACTIVITY; REVIEW; RISK ASSESSMENT; TESTIS DEVELOPMENT; VIRILIZATION;

ANDROGENS; ENVIRONMENTAL POLLUTANTS; HUMANS; HYPOSPADIAS; INCIDENCE; MALE; TESTOSTERONE; WORLD HEALTH;

EID: 13444266414     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (116)

1. Glenister TW. A correlation of the normal and abnormal development of the penile urethra and of the infra-umbilical abdominal wall. British Journal of Urology 1958;30:117-126
2. Glenister TW. The origin and fate of the urethral plate in man. Journal of Anatomy 1954;88(3):413-424
3. Kurzrock EA, Baskin LS, Cunha GR. Ontogeny of the male urethra: theory of endodermal differentiation. Differentiation 1999;64(2):115-122
4. Kurzrock EA, Baskin LS, Li Y, Cunha GR. Epithelial-mesenchymal interactions in development of the mouse fetal genital tubercle. Cells Tissues Organs 1999;164(3):125-130
5. Baskin LS, Erol A, Jegatheesan P, Li Y, Liu W, Cunha GR. Urethral seam formation and hypospadias. Cell Tissue Res 2001;305(3):379-87.
6. Wilson JD, Griffin JE, Russell DW. Steroid 5 alpha-reductase 2 deficiency. Endocr Rev 1993;14(5):577-593
7. Grumbach MM, Gluckman PD. The Human Fetal Hypothalamus and Pituitary Gland. In: Tulchinsky D, Little AB, eds. Maternal-Fetal Endocrinology. 2 ed, Philadelphia: W. B. Saunders, 1994:193-261
8. Kallen B, Bertollini R, Castilla E, et al. A joint international study on the epidemiology of hypospadias. Acta Paediatr Scand Suppl 1986;324:1-52
9. Paulozzi LJ, Erickson D, Jackson RJ. Hypospadias trends in two US surveillance systems. Pediatrics 1997;100(5):831-834
10. Matlai P, Beral V. Trends in congenital malformations of external genitalia. Lancet 1985;1:108-112
11. Kallen B, Winberg J. An epidemiological study of hypospadias in Sweden. Acta Paediatrics Scandanavia Supplement 1982;293:3-21
12. Czeizel A. Increasing trends in congenital malformations of male external genitalia. Lancet 1985;1:462-463
13. Campbell H, Newcombe RG, Weatherall JA. Epidemiology of simple hypospadias. Br Med J 1973;iii:52-53
14. Bjerkedal T, Bakketeig LS. Surveillance of congenital malformations and other conditions of the newborn. Int J Epidemiol 1975;4:31-36
15. Pierik FH, Burdorf A, Nijman JM, de Muinck Keizer-Schrama SM, Juttmann RE, Weber RF. A high hypospadias rate in The Netherlands. Hum Reprod 2002;17(4):1112-5
16. Bauer SB, Retik AB, Colodny AH. Genetic aspects of hypospadias. Urol Clin North Am 1981;8(3):559-64
17. Harris EL, Beaty TH. Segregation analysis of hypospadias: a reanalysis of published pedigree data. Am J Med Genet 1993;45(4):420-5
18. Sorenson HR. Hypospadias with special reference to aetiology. Copenhagen: Munksgaard, 1953
19. Fredell L, Lichtenstein P, Pedersen NL, Svensson J, Nordenskjold A. Hypospadias is related to birth weight in discordant monozygotic twins. J Urol 1998;160(6 Pt 1):2197-2199
20. Fredell L, Kockum I, Hansson E, et al. Heredity of hypospadias and the significance of low birth weight. J Urol 2002;167(3):1423-1427
21. Hussain N, Chaghtai A, Herndon CD, Herson VC, Rosenkrantz TS, McKenna PH. Hypospadias and early gestation growth restriction in infants. Pediatrics 2002;109(3):473-478
22. Albers N, Ulrichs C, Gluer S, et al. Etiologic classification of severe hypospadias: implications for prognosis and management. J Pediatr 1997;131(3):386-92.
23. Yamasuchi T, Kitada S, Osada Y. Chromosomal anomalies in cryptorchidism and hypospadias. Urol Int 1991;47(2):60-63
24. Boehmer AL, Nijman RJ, Lammers BA, et al. Etiological studies of severe or familial hypospadias. J Urol 2001;165(4):1246-1254
25. Yabumoto H, Fichtner J, Shima H, Ikoma F, Sakamoto H, Furuyama J. [Chromosome abnormalities in hypospadias? An analysis of 131 patients]. Urologe A 1992;31(4):227-230
26. Moreno-Garcia M, Miranda EB. Chromosomal anomalies in cryptorchidism and hypospadias. J Urol 2002;168(5):2170-2; discussion 2172
27. Rajfer J, Walsh PC. The incidence of intersexuality in patients with hypospadias and cryptorchidism. J Urol 1976;116(6):769-770
28. Rohatgi M, Menon PS, Verma IC, Iyengar JK. The presence of intersexuality in patients with advanced hypospadias and undescended gonads. J Urol 1987;137(2):263-267
29. Kaefer M, Diamond D, Hendren WH, et al. The incidence of intersexuality in children with cryptorchidism and hypospadias: stratification based on gonadal palpability and meatal position. J Urol 1999;162(3 Pt 2):1003-1006; discussion 1006-1007
30. Siiteri PK, Wilson JD. Testosterone formation and metabolism during male sexual differentiation in the human embryo. J Clin Endocrinol Metab 1974;38(1):113-125
31. Reyes FI, Boroditsky RS, Winter JS, Faiman C. Studies on human sexual development. II. Fetal and maternal serum gonadotropin and sex steroid concentrations. J Clin Endocrinol Metab 1974;38(4):612-617
32. Okuyama A, Namiki M, Koide T, et al. Pituitary and gonadal function in prepubertal and pubertal boys with hypospadias. Acta Endocrinologica 1981;98(3):464-469
33. Shima H, Ikoma F, Yabumoto H, et al. Gonadotropin and testosterone response in prepubertal boys with hypospadias. J Urol. 1986;135(3):539-542
34. Nonomura K, Fujieda K, Sakakibara N, et al. Pituitary and gonadal function in prepubertal boys with hypospadias. J Urol 1984;132(3):595-598
35. Allen TD, Griffin JE. Endocrine studies in patients with advanced hypospadias. J Urol 1984;131(2):310-314
36. Knorr D, Beckmann D, Bidlinsmaier F, Helmig FJ, Sippell WG. Plasma testosterone in male puberty. II. hCG stimulation test in boys with hypospadia. Acta Endocrinol (Copenh) 1979;90(2):365-371
37. Walsh PC, Curry N, Mills RC, Siiteri PK. Plasma androgen response to hCG stimulation in prepubertal boys with hypospadias and cryptorchidism. J Clin Endocrinol Metab 1976;42(1):52-59
38. Svensson J, Eneroth P, Gustafsson JA, Ritzen M, Stenbers A. Metabolism of androstenedione in skin and serum levels of gonadotrophins and androgens in prepubertal boys with hypospadias. J Endocrinol 1978;76(3):399-409
39. Feyaerts A, Forest MG, Morel Y, et al. Endocrine screening in 32 consecutive patients with hypospadias. J Urol 2002;168(2):720-725; discussion 725
40. Gearhart JP, Donohoue PA, Brown TR, Walsh PC, Berkovitz GD. Endocrine evaluation of adults with mild hypospadias. J Urol 1990;144(2 Pt 1):274-277
41. Aaronson IA, Cakmak MA, Key LL. Defects of the testosterone biosynthetic pathway in boys with hypospadias [In Process Citation]. J Urol 1997;157(5):1884-1888
42. Holmes NM, Miller WL, Baskin LS. Defects in androgen production as a role in the etiology of hypospadias. American Academy of Pediatrics 2001, San Francisco.
43. Kiely EA, Chapman RS, Bajoria SK, Hollyer JS, Hurley R. Maternal serum human chorionic gonadotrophin during early pregnancy resulting in boys with hypospadias or cryptorchidism. Br J Urol 1995;76(3):389-392
44. Monteleone Neto R, Castilla EE, Paz JE. Hypospadias: an epidemiological study in Latin America. Am J Med Genet 1981;10(1):5-19
45. Wehruns DA, Hay S. A study of seasonal incidence of congenital malformations in the United States. Br J Prev Soc Med 1970;24(1):24-32
46. Roberts CJ, Lloyd S. Observations on the epidemiology of simple hypospadias. Br Med J 1973;1(5856):768-770
47. Sweet RA, Schrott HG, Kurland R, Culp OS. Study of the incidence of hypospadias in Rochester, Minnesota, 1940-1970, and a case-control comparison of possible etiologic factors. Mayo Clin Proc 1974;49(1):52-58
48. Czeizel A, Toth J, Erodi E. Aetiological studies of hypospadias in Hungary. Hum Hered 1979;29(3):166-171
49. Kurzrock EA, Baskin LS, Jegatheesan P, Cunha GR. Urethral development in the fetal rabbit and induction of hypospadias: a model of human development. Western Section of American Urological Association 1999, Monterey, CA.
50. Prahalada S, Tarantal AF, Harris GS, et al. Effects of finasteride, a type 2 5-alpha reductase inhibitor, on fetal development in the rhesus monkey (Macaca mulatta). Teratology 1997;55(2):119-131
51. Schweikert HU, Schluter M, Romalo G. Intracellular and nuclear binding of [3H]dihydrotestosterone in cultured genital skin fibroblasts of patients with severe hypospadias. J Clin Invest 1989;83(2):662-668
52. Gearhart JP, Linhard HR, Berkovitz GD, Jeffs RD, Brown TR. Androgen receptor levels and 5 alpha-reductase activities in preputial skin and chordee tissue of boys with isolated hypospadias. J Urol 1988;140(5 Pt 2):1243-1246
53. Silver RI, Russell DW. Salpha-reductase type 2 mutations are present in some boys with isolated hypospadias. J Urol 1999;162(3 Pt 2):1142-1145
54. Nordenskjold A, Friedman E, Tapper-Persson M, et al. Screening for mutations in candidate genes for hypospadias. Urol Res 1999;27(1):49-55
55. Truss M, Beato M. Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocr Rev 1993;14(4):459-479
56. Kim S, Liu W, Cunha GR, et al. Expression of the androgen receptor and 5alpha-reductase type 2 in the developing human fetal penis and urethra. Cell Tissue Res 2002;307(2):145-153
57. Kalloo NB, Gearhart JP, Barrack ER. Sexually dimorphic expression of estrogen receptors, but not of androgen receptors in human fetal external genitalia. Journal of Urology 1993;77(3):692-698
58. Veyssiere G, Berger M, Jean-Faucher C, de Turckheim M, Jean C. Androgen receptor in genital tubercle of rabbit fetuses and newborns. Ontogeny and properties. J Steroid Biochem 1985;23(4):399-404
59. Roehrborn CG, Lange JL, George FW, Wilson JD. Changes in amount and intracellular distribution of androgen receptor in human foreskin as a function of age. J Clin Invest 1987;79(1):44-47
60. Herkner K, Swoboda W, Hoeller B, Goedl U. Molecular biology of androgen action: testosterone/dihydrotestosterone receptor and androgen 5 alpha-reductase in the human foreskin. J Steroid Biochem 1986;24(1):239-243
61. Baskin LS, Sutherland RS, DiSandro MJ, Hayward SW, Lipschutz J, Cunha GR. The effect of testosterone on androgen receptors and human penile growth. J Urol 1997;158(3 Pt 2):1113-1118
62. Levy JB, Seay TM, Tindall DJ, Husmann DA. The effects of androgen administration on phallic androgen receptor expression. J Urol 1996;156(2 Pt 2):775-779
63. Shen R, Lin MC, Sadeghi F, Swerdloff RS, Rajfer J, Gonzalez-Cadavid NF. Androgens are not major down-regulators of androgen receptor levels during growth of the immature rat penis. J Steroid Biochem Mol Biol 1996;57(5-6):301-313
64. Husmann DA, Cain MP. Microphallus: eventual phallic size is dependent on the timing of androgen administration. J Urol 1994;152 (2 Pt 2):734-739
65. Lin MC, Rajfer J, Swerdloff RS, Gonzalez-Cadavid NF. Testosterone down-regulates the levels of androgen receptor mRNA in smooth muscle cells from the rat corpora cavernosa via aromatization to estrogens. J Steroid Biochem Mol Biol 1993;45(5):333-343
66. Takane KK, Husmann DA, McPhaul MJ, Wilson JD. Androgen receptor levels in the rat penis are controlled differently in distinctive cell types. Endocrinology 1991;128(5):2234-2238
67. Fichman KR, Nyberg LM, Bujnovszky P, Brown TR, Walsh PC. The ontogeny of the androgen receptor in human foreskin. J Clin Endocrinol Metab 1981;52(5):919-923
68. Tincello DG, Saunders PT, Hodgins MB, et al. Correlation of clinical, endocrine and molecular abnormalities with in vivo responses to high-dose testosterone in patients with partial androgen insensitivity syndrome. Clin Endocrinol (Oxf) 1997;46(4):497-506
69. Nakao R, Yanase T, Sakai Y, Haji M, Nawata H. A single amino acid substitution (gly743 > val) in the steroid-binding domain of the human androgen receptor leads to Reifenstein syndrome. J Clin Endocrinol Metab 1993;77(1):103-107
70. Keenan BS, McNeel RL, Gonzales ET. Abnormality of intracellular 5 alpha-dihydrotestosterone binding in simple hypospadias: studies on equilibrium steroid binding in sonicates of genital skin fibroblasts. Pediatr Res 1984;18(2):216-220
71. Svensson J, Snochowski M. Androgen receptor levels in preputial skin from boys with hypospadias. J Clin Endocrinol Metab 1979;49(3):340-345
72. Eil C, Crawford JD, Donahoe PK, Johnsonbaugh RE, Loriaux DL. Fibroblast androgen receptors in patients with genitourinary anomalies. J Androl 1984;5(5):313-320
73. Evans BA, Williams DM, Hughes IA. Normal postnatal androgen production and action in isolated micropenis and isolated hypospadias. Arch Dis Child 1991;66(9):1033-1036
74. Terakawa T, Shima H, Yabumoto H, Koyama K, Ikoma F. Androgen receptor levels in patients with isolated hypospadias. Acta Endocrinol (Copenh) 1990;123(1):24-29
75. Coulam CB, Razel AJ, Kelalis PP, Svensson J, Spelsberg TC. Androgen receptor in human foreskin. II. Characterization of the receptor from hypospadiac tissue. Am J Obstet Gynecol 1983;147(5):513-520
76. Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 1995;16(3):271-321
77. Batch JA, Davies HR, Evans BA, Hughes IA, Patterson MN. Phenotypic variation and detection of carrier status in the partial androgen insensitivity syndrome. Arch Dis Child 1993;68(4):453-457
78. Lim HN, Nixon RM, Chen H, Hughes IA, Hawkins JR. Evidence that longer androgen receptor polyglutamine repeats are a causal factor for genital abnormalities. J Clin Endocrinol Metab 2001;86(7):3207-3210
79. Kaspar F, Cato AC, Denninger A, et al. Characterization of two point mutations in the androgen receptor gene of patients with perineoscrotal hypospadia. J Steroid Biochem Mol Biol 1993;47(1-6):127-135
80. Allera A, Herbst MA, Griffin JE, Wilson JD, Schweikert HU, McPhaul MJ. Mutations of the androgen receptor coding sequence are infrequent in patients with isolated hypospadias. J Clin Endocrinol Metab 1995;80(9):2697-2699
81. Hiort O, Klauber G, Cendron M, et al. Molecular characterization of the androgen receptor gene in boys with hypospadias. Eur J Pediatr 1994;153(5):317-21.
82. Muroya K, Sasagawa I, Suzuki Y, Nakada T, Ishii T, Ogata T. Hypospadias and the androgen receptor gene: mutation screening and CAG repeat length analysis. Mol Hum Reprod 2001;7(5):409-413
83. Sutherland RW, Wiener JS, Hicks JP, et al. Androgen receptor gene mutations are rarely associated with isolated penile hypospadias. J Urol 1996;156(2 Pt 2):828-831
84. McPhaul MJ, Schweikert HU, Allman DR. Assessment of androgen receptor function in genital skin fibroblasts using a recombinant adenovirus to deliver an androgen-responsive reporter gene [published erratum appears in J Clin Endocrinol Metab 1997 Aug;82(8):2670]. J Clin Endocrinol Metab 1997;82(6):1944-1948
85. McPhaul MJ, Schweikert HU, Allman DR. Assessment of androgen receptor function in genital skin fibroblasts using a recombinant adenovirus to deliver an androgen-responsive reporter gene [published erratum appears in J Clin Endocrinol Metab 1997 Aug;82(8):2670]. J Clin Endocrinol Metab 1997;82(6):1944-1948
86. Teixeira J, Fynn-Thompson E, Payne AH, Donahoe PK. Mullerian-inhibiting substance regulates androgen synthesis at the transcriptional level. Endocrinology 1999;140(10):4732-4738
87. Lyet L, Louis F, Forest MG, Josso N, Behringer RR, Vigier B. Ontogeny of reproductive abnormalities induced by deregulation of anti-mullerian hormone expression in transgenic mice. Biol Reprod 1995;52(2):444-454
88. Behringer RR, Cate RL, Froelick GJ, Palmiter RD, Brinster RL. Abnormal sexual development in transgenic mice chronically expressing mullerian inhibiting substance. Nature 1990;345(6271):167-170
89. Ritchey ML, Benson RC, Jr., Kramer SA, Kelalis PP. Management of mullerian duct remnants in the male patient. J Urol 1988;140(4):795-799
90. Austin PF, Siow Y, Fallat ME, Cain MP, Rink RC, Casale AJ. The relationship between mullerian inhibiting substance and androgens in boys with hypospadias. J Urol 2002;168(4 Pt 2):1784-8; discussion 1788
91. Carlsen E, Giwercman A, Keiding N, Skakkebaek NE. Evidence for decreasing quality of semen during past 50 years. Bmj 1992;305(6854):609-613
92. Paulozzi LJ. International trends in rates of hypospadias and cryptorchidism. Environ Health Perspect 1999;107(4):297-302
93. Toppari J, Larsen JC, Christiansen P, et al. Male reproductive health and environmental xenoestrogens. Environ Health Perspect 1996;104 Suppl 4:741-803
94. Dolk H, Vrijheid M, Armstrong B, et al. Risk of congenital anomalies near hazardous-waste landfill sites in Europe: the EUROHAZCON study. Lancet 1998;352(9126):423-427
95. Brock JW, Melnyk LJ, Caudill SP, Needham LL, Bond AE. Serum levels of several organochlorine pesticides in farmers correspond with dietary exposure and local use history. Toxicol Ind Health 1998;14(1-2):275-289
96. Sonawane BR. Chemical contaminants in human milk: an overview. Environ Health Perspect 1995;103 Suppl 6:197-205
97. Henderson BE, Benton B, Cosgrove M, et al. Urogenital tract abnormalities in sons of women treated with diethylstilbestrol. Pediatrics 1976;58(4):505-507
98. Wilcox AJ, Baird DD, Weinberg CR, Hornsby PP, Herbst AL. Fertility in men exposed prenatally to diethylstilbestrol. N Engl J Med 1995;332(21):1411-1416
99. Klip H, Verloop J, van Cool JD, Koster ME, Burger CW, van Leeuwen FE. Hypospadias in sons of women exposed to diethylstilbestrol in utero: a cohort study. Lancet 2002;359(9312):1102-1107
100. Verdeal K, Brown RR, Richardson T, Ryan DS. Affinity of phytoestrogens for estradiol-binding proteins and effect of coumestrol on growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors. J Natl Cancer Inst 1980;64(2):285-290
101. North K, Golding J. A maternal vegetarian diet in pregnancy is associated with hypospadias. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. BJU Int 2000;85(1):107-113
102. Kong KS, Che JH, Lee YS. Lack of adverse effects in the F1 offspring maternally exposed to genistein at human intake dose level. Food Chem Toxicol 2002;40(1):43-51
103. Wisniewski AB, Klein SL, Lakshmanan Y, Gearhart JP. Exposure to genistein during gestation and lactation demasculinizes the reproductive system in rats. J Urol 2003;169(4):1582-1586
104. Kelce WR, Stone CR, Laws SC, Gray LE, Kemppainen JA, Wilson EM. Persistent DDT metabolite p,p'-DDE is a potent androgen receptor antagonist. Nature 1995;375(6532):581-585
105. Kelce WR, Lambright CR, Gray LE, Jr., Roberts KP. Vinclozolin and p,p'-DDE alter androgen-dependent gene expression: in vivo confirmation of an androgen receptor-mediated mechanism. Toxicol Appl Pharmacol 1997;142(1):192-200
106. Gray LE, Jr., Wolf C, Lambright C, et al. Administration of potentially antiandrogenic pesticides (procymidone, linuron, iprodione, chlozolinate, p,p'-DDE, and ketoconazole) and toxic substances (dibutyl- and diethylhexyl phthalate, PCB 169, and ethane dimethane sulphonate) during sexual differentiation produces diverse profiles of reproductive malformations in the male rat. Toxicol Ind Health 1999;15(1-2):94-118
107. Wolf CJ, LeBlanc GA, Ostby JS, Gray LE, Jr. Characterization of the period of sensitivity of fetal male sexual development to vinclozolin. Toxicol Sci 2000;55(1):152-161
108. Ostby J, Kelce WR, Lambright C, Wolf CJ, Mann P, Gray LE, Jr. The fungicide procymidone alters sexual differentiation in the male rat by acting as an androgen-receptor antagonist in vivo and in vitro. Toxicol Ind Health 1999;15(1-2):80-93
109. Lambright C, Ostby J, Bobseine K, et al. Cellular and molecular mechanisms of action of linuron: an antiandrogenic herbicide that produces reproductive malformations in male rats. Toxicol Sci 2000;56(2):389-399
110. Macnab AJ, Zouves C. Hypospadias after assisted reproduction incorporating in vitro fertilization and gamete intrafallopian transfer. Fertil Steril 1991;56(5):918-922
111. Silver RI, Rodriguez R, Chang TS, Gearhart JP. In vitro fertilization is associated with an increased risk of hypospadias. J Urol 1999;161(6):1954-1957
112. Aarskog D. Maternal progestins as a possible cause of hypospadias. N Engl J Med 1979;300(2):75-78
113. Ericson A, Kallen B. Congenital malformations in infants born after IVF: a population-based study. Hum Reprod 2001;16(3):504-509
114. Bonduelle M, Legein J, Derde MP, et al. Comparative follow-up study of 130 children born after intracytoplasmic sperm injection and 130 children born after in-vitro fertilization. Hum Reprod 1995;10(12):3327-3331
115. Wennerholm UB, Bergh C, Hamberger L, et al. Incidence of congenital malformations in children born after ICSI. Hum Reprod 2000;15(4):944-948
116. Fritz G, Czeizel AE. Abnormal sperm morphology and function in the fathers of hypospadiacs. J Reprod Fertil 1996;106(1):63-66